Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis.
Central Nervous System Expression and PET Imaging of the Translocator Protein in Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study.
Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
Fine-tuning of type I IFN-signaling in microglia - implications for homeostasis, CNS autoimmunity and interferonopathies.
Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.
Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
[Multiple sclerosis and pregnancy].
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Discovery of novel disease-specific and membrane-associated markers in a mouse model of multiple sclerosis.
Tropical myelopathies.
Relationship between subjective and objective cognitive performance in multiple sclerosis.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Genomic Binding Sites and Biological Effects of the Vitamin D: VDR Complex in Multiple Sclerosis.
[Cognitive impairment in multiple sclerosis].
Dietary habits and selenium, glutathione peroxidase and total antioxidant status in the serum of patients with relapsing-remitting multiple sclerosis.
Experiences of hospitalization in patients with multiple sclerosis: A qualitative study.
Gait kinematics of people with Multiple Sclerosis and the acute application of Functional Electrical Stimulation.
Development of therapies for autoimmune disease at Stanford: a tale of multiple shots and one goal.
Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.
Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept.
Genetic analysis of the isolated Faroe Islands reveals SORCS3 as a potential multiple sclerosis risk gene.
Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes.
Pages
« first
‹ previous
…
426
427
428
429
430
431
432
433
434
…
next ›
last »